Travere Therapeutics (TVTX) Times Interest Earned (2011 - 2026)
Travere Therapeutics (TVTX) reported Times Interest Earned of -$16.05 for Q1 2026, down 7.45% on a YoY basis from -$17.34 in Q1 2025, and down 11.26% quarter-over-quarter from -$14.43 in Q4 2025.
Travere Therapeutics (TVTX) Times Interest Earned (2011 - 2026) Analysis & Trends
Travere Therapeutics has reported Times Interest Earned for 8 years, with the latest figure at -$16.05 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned fell 7.45% year-over-year to -$16.05; the trailing twelve-month figure through Mar 2026 stood at -$5.65 (up 72.06% YoY), and the FY2025 full-year result was -$5.87, up 79.73% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$16.05, down from -$14.43 in the prior quarter.
- The five-year high for Times Interest Earned was $9.06 in Q3 2025, with the low at -$49.73 in Q1 2024.
- Historically, Times Interest Earned has averaged -$21.68 across 4 years, with a median of -$20.94 in 2024.
- Annual changes were most pronounced in 2025 — Times Interest Earned surged 145.19% — and 2026, when it retreated 7.45%.
- Travere Therapeutics' Times Interest Earned stood at -$33.25 in 2023, then soared by 34.34% to -$21.83 in 2024, then soared by 33.93% to -$14.43 in 2025, then dropped by 11.26% to -$16.05 in 2026.
- The last three Times Interest Earned figures came in at -$16.05 (Q1 2026), -$14.43 (Q4 2025), and $9.06 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Travere Therapeutics | 5.07 Bn | 4.99 Bn | 102.38 Mn | -16.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.05 |
| Dec 31, 2025 | -14.43 |
| Sep 30, 2025 | 9.06 |
| Jun 30, 2025 | -4.52 |
| Mar 31, 2025 | -14.94 |
| Dec 31, 2024 | -21.83 |
| Sep 30, 2024 | -20.05 |
| Jun 30, 2024 | -24.18 |
| Mar 31, 2024 | -49.73 |
| Dec 31, 2023 | -33.25 |
| Sep 30, 2023 | -33.07 |
| Jun 30, 2023 | -37.13 |
| Dec 31, 2014 | -7.10 |
| Sep 30, 2014 | -8.41 |
| Dec 31, 2013 | -2,435.06 |
| Mar 31, 2013 | 54.13 |
| Aug 31, 2012 | -6.00 |
| May 31, 2012 | -6.02 |
| Aug 31, 2011 | -6.05 |